AI cancer cures slowed by chip shortage, says UK's biggest tech boss — SkimNews
Get the Tech newsletter
Daily tech — startups, AI labs, chips, the launches that shape the next decade. Free.
- Arm Holdings CEO Rene Haas said AI will help cure cancer in our lifetimes by solving problems 'too complex' for current computers, but warned the AI rollout is bottlenecked by a chip supply shortage.
- Haas said the industry is 'absolutely in a supply-constrained environment,' pointing to plans for multi-gigawatt data centers in France, the US, and space that cannot proceed without more chip fabs.
- Meta commissioned Arm to build the Arm AGI chip, generating more than $2bn in demand since its March launch; Arm's power-efficient technology now powers half of all AI data centers worldwide.
- Haas predicted widespread humanoid robots in manufacturing, cleaning, security, and construction within a decade, but called fears of mass AI-driven job losses 'a bit overstated.'
- Prof Chris Bakal of the Institute of Cancer Research countered that the future of medical AI 'will not belong to whoever builds the biggest computer' but to whoever has the right patient-data measurements, training AI on lab-generated samples rather than scraped internet data.
- Haas was skeptical about UK chip manufacturing, saying fabs are 'very expensive' and require specialized workers, despite government talks about bringing parts of the physical chip supply chain to Britain.
Why it matters: Arm's commercial evolution from IP licensor to chip seller is accelerating — the $2bn+ AGI chip demand from Meta since March shows it can monetize AI's appetite for custom silicon. But Haas himself conceded the supply crunch is bottlenecking the multi-gigawatt data center builds those chips are meant to power, and shut down UK hopes for domestic fabs.
Ask SkimNews
